申请人:Wang Ying
公开号:US08518933B2
公开(公告)日:2013-08-27
The present application relates to 1,2,3,4,4a,5,6,7-octahydropyrazino[1,2 -a][1,4]benzodiazepine, 1,2,3,4,4a,5,6,7-octahydropyrazino[1,2-a][1,5]benzodiazepine, 2,3,4,4a,5,6,7,11b-octahydro-1H-pyrido[3,4-d][2]benzazepine, 1,2,3,4,4a,5,6,7 -octahydropyrazino[1,2-a][1]benzazepine, 1,2,3,4,4a,5-hexahydro-7H-pyrazino[1,2 -a][4,1]benzoxazepine, and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[2,1-d][1,5]benzoxazepine, and 5,6,7,7a,8,9,10,11-octahydropyrazino[1,2-d]pyrido[3,2-b][1,4]diazepine derivatives of formula (I)
wherein R1, R2, R3, R4, R5, R6, X1, X2, X3, X4, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.
本申请涉及以下式子的衍
生物:1,2,
3,4,4a,5,6,7-八
氢吡嗪并[1,2-a][1,4]
苯二
氮平,1,2,
3,4,4a,5,6,7-八
氢吡嗪并[1,2-a][1,5]
苯二
氮平,2,
3,4,4a,5,6,7,11b-八
氢-1H-
吡啶并[3,4-d][2]
苯并
氮平,1,2,
3,4,4a,5,6,7-八
氢吡嗪并[1,2-a][1]
苯并
氮平,1,2,
3,4,4a,5-六
氢-7H-
吡嗪并[1,2-a][4,1]
苯并
噁唑平,2,
3,4,4a,5,6-六
氢-1H-
吡嗪并[2,1-d][1,5]
苯并
噁唑平,以及式(I)中R1、R2、R3、R4、R5、R6、X1、X2、X3、X4、Y1、Y2和Y3如说明书所定义的衍
生物。本申请还涉及包含这样的化合物的组合物,以及使用这样的化合物和组合物治疗疾病病状的方法,以及鉴定这样的化合物的方法。